Correlation Between Novozymes and Sika AG

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novozymes and Sika AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novozymes and Sika AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novozymes AS B and Sika AG, you can compare the effects of market volatilities on Novozymes and Sika AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novozymes with a short position of Sika AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novozymes and Sika AG.

Diversification Opportunities for Novozymes and Sika AG

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Novozymes and Sika is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Novozymes AS B and Sika AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sika AG and Novozymes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novozymes AS B are associated (or correlated) with Sika AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sika AG has no effect on the direction of Novozymes i.e., Novozymes and Sika AG go up and down completely randomly.

Pair Corralation between Novozymes and Sika AG

Assuming the 90 days horizon Novozymes AS B is expected to generate 0.94 times more return on investment than Sika AG. However, Novozymes AS B is 1.06 times less risky than Sika AG. It trades about -0.08 of its potential returns per unit of risk. Sika AG is currently generating about -0.11 per unit of risk. If you would invest  6,725  in Novozymes AS B on September 12, 2024 and sell it today you would lose (935.00) from holding Novozymes AS B or give up 13.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Novozymes AS B  vs.  Sika AG

 Performance 
       Timeline  
Novozymes AS B 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novozymes AS B has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Sika AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sika AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Novozymes and Sika AG Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novozymes and Sika AG

The main advantage of trading using opposite Novozymes and Sika AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novozymes position performs unexpectedly, Sika AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sika AG will offset losses from the drop in Sika AG's long position.
The idea behind Novozymes AS B and Sika AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas